Molecule
16 known investors
Find your way into Molecule
Molecule operates a blockchain-based platform supporting decentralized science (DeSci), funding research projects and connecting scientists and entrepreneurs. It also features labs such as an autonomous AI agent for peptide drug discovery.
Founders & leadership
PK
Paul KohlhaasinFounder
Investors · 16
BackedLondon · $500K – $5M
CompoundNew York · $400K – $1.5M
Fifty YearsSan Francisco · $250K – $2M
Inflection.xyzBoston · $500K – $2M
Lunar VenturesBerlin · $500K – $2M
Shine CapitalNew York · $1M – $10M
Signature VenturesAying
AME Cloud Venturesreported · 2 sourcesPalo Alto · $1M – $10M
ChemistryreportedSan Francisco
Cherubic Venturesreported · 2 sourcesGrand Cayman · $220K – $27M
KdT VenturesreportedAustin · $500K – $3M
Mercury FundreportedHouston · $250K – $4M
Sutter Hill VenturesreportedPalo Alto · $100K – $5M
Also in the syndicate · 3
Atmos VenturesleadInVenturesSunfish Partners
Funding
SEC filings, press & company announcements- Undisclosed amountseed fundingJun 2021
Atmos Ventures (lead), AME Cloud Ventures, Cherubic Ventures, Firlej Kastory, InVentures, Luminous Ventures, Sunfish Partners
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
Competitors · 4
by search overlap
Molecule ONE24 shared keywordsMolecule.one applies machine learning to chemical synthesis, predicting synthetic routes and supporting chemistry research with an in-house synthetic and analytical laboratory. It serves pharmaceutical and life-science research through its computational and experimental chemistry platform.
Emolecules17 shared keywordseMolecules operates a digital chemical search platform and procurement service connecting researchers to over 83 million available chemical compounds from a global supplier network. The company serves drug discovery researchers and biopharmaceutical organizations seeking to reduce timelines and improve efficiencies in early-stage compound acquisition and management.
Molecular Devices17 shared keywordsMolecular Devices provides automated systems and services to support 3D cell biology research workflows, including cell culture automation, organoid expansion services, and imaging analysis tools for drug discovery and preclinical research.
CoinGecko14 shared keywordsCoinGecko is the world's largest independent cryptocurrency data aggregator, providing comprehensive market data including price, volume, and market capitalization across thousands of cryptoassets. It serves millions of users globally with tools, research, and APIs for cryptocurrency market analysis and insights.
Companies competing with Molecule for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Khartis Therapeutics Emerges from Stealth with $95 Million in Funding to Advance Oral Small Molecule Immunology Pipeline - BioSpacebiospace.com · Aug 2026Frequently asked questions
- What does Molecule do?
- Molecule operates a blockchain-based platform supporting decentralized science (DeSci), funding research projects and connecting scientists and entrepreneurs. It also features labs such as an autonomous AI agent for peptide drug discovery.
- Who founded Molecule?
- Molecule was founded by Paul Kohlhaas.
- Who are Molecule's investors?
- Molecule's investors include Backed, Compound, Fifty Years, Inflection.xyz, Lunar Ventures, Shine Capital, Signature Ventures, AME Cloud Ventures and 5 more.